SARS-CoV-2 and its ORF3a, E and M viroporins activate inflammasome in human macrophages and induce of IL-1α in pulmonary epithelial and endothelial cells
Open Access
- 25 April 2024
- journal article
- research article
- Published by Springer Nature in Cell Death Discovery
- Vol. 10 (1) , 1-11
Abstract
Inflammasome assembly is a potent mechanism responsible for the host protection against pathogens, including viruses. When compromised, it can allow viral replication, while when disrupted, it can perpetuate pathological responses by IL-1 signaling and pyroptotic cell death. SARS-CoV-2 infection was shown to activate inflammasome in the lungs of COVID-19 patients, however, potential mechanisms responsible for this response are not fully elucidated. In this study, we investigated the effects of ORF3a, E and M SARS-CoV-2 viroporins in the inflammasome activation in major populations of alveolar sentinel cells: macrophages, epithelial and endothelial cells. We demonstrated that each viroporin is capable of activation of the inflammasome in macrophages to trigger pyroptosis-like cell death and IL-1α release from epithelial and endothelial cells. Small molecule NLRP3 inflammasome inhibitors reduced IL-1 release but weakly affected the pyroptosis. Importantly, we discovered that while SARS-CoV-2 could not infect the pulmonary microvascular endothelial cells it induced IL-1α and IL-33 release. Together, these findings highlight the essential role of macrophages as the major inflammasome-activating cell population in the lungs and point to endothelial cell expressed IL-1α as a potential novel component driving the pulmonary immunothromobosis in COVID-19.Keywords
Funding Information
- Narodowe Centrum Nauki (UMO-2020/01/0/NZ6/00218 (COVID-19), UMO-2020/01/0/NZ6/00218 (COVID-19), UMO-2020/01/0/NZ6/00218 (COVID-19), UMO-2020/01/0/NZ6/00218 (COVID-19), UMO-2020/01/0/NZ6/00218 (COVID-19), UMO-2020/01/0/NZ6/00218 (COVID-19))
- Bundesministerium für Forschung, Technologie und Raumfahrt (13N15745, 13N15745, 13N15745)
This publication has 47 references indexed in Scilit:
- An epithelial-immune circuit amplifies inflammasome and IL-6 responses to SARS-CoV-2Cell Host & Microbe, 2022
- DFV890: a new oral NLRP3 inhibitor—tested in an early phase 2a randomised clinical trial in patients with COVID-19 pneumonia and impaired respiratory functionInfection, 2022
- Effect of Colchicine vs Usual Care Alone on Intubation and 28-Day Mortality in Patients Hospitalized With COVID-19JAMA Network Open, 2021
- IL-33 Depletion in COVID-19 LungsChest, 2021
- Glycyrrhizin prevents SARS-CoV-2 S1 and Orf3a induced high mobility group box 1 (HMGB1) release and inhibits viral replicationCytokine, 2021
- Inflammasome regulation in driving COVID-19 severity in humans and immune tolerance in batsJournal of Leukocyte Biology, 2021
- Detection of viruses by inflammasomesCurrent Opinion in Virology, 2021
- Endothelial cells are not productively infected by SARS‐CoV‐2Clinical & Translational Immunology, 2021
- The Coagulation and Immune Systems Are Directly Linked through the Activation of Interleukin-1α by ThrombinImmunity, 2019
- An update on the NLRP3 inflammasome and influenza: the road to redemption or perdition?Current Opinion in Immunology, 2018